RxDoctor Payments Data

Danielle Kizzie

Family · Pueblo, CONPI 1780460592

Payments from drug & device makers

$1,315in general payments, 2019–2025

Across 67 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$276
  • AstraZeneca$185
  • AbbVie$154
  • Novartis$111
  • Novo Nordisk$95
  • Aimmune Therapeutics, Inc.$61
  • plus $434 from 15 others

What the payments were for

  • Food & beverage$1,315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,315 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$21,253
Medicare patients
102
Services billed
269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,112
Albuterol Sulfate HfaAlbuterol Sulfate27$617
Omeprazole28$372
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$364
Aripiprazole11$337
Venlafaxine Hcl ErVenlafaxine Hcl11$239
Lisinopril34$202
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$202
Nystatin14$163
Fluticasone Propionate11$163
Rosuvastatin Calcium14$139
Azithromycin33$129
Atorvastatin Calcium20$125
Amlodipine Besylate17$116
Levothyroxine Sodium27$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$33$11,11211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,182 family providers in Colorado.

Other family in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →